Position in INCY
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$5,311,849
+$5,055,739 QoQ
Shares Held
56,437
+2076.5% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Jump Financial, LLC holds $441,725,895 across 169 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
306,330 | $24,288,904 | |
| 2 | VKTX |
Viking Therapeutics, Inc.
|
579,882 | $22,621,196 | |
| 3 | XENE |
Xenon Pharmaceuticals Inc.
|
260,730 | $15,737,662 | |
| 4 | CRSP |
CRISPR Therapeutics AG
|
277,952 | $15,159,500 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
245,390 | $14,041,214 | |
| 6 | SRPT |
Sarepta Therapeutics, Inc.
|
679,445 | $12,209,626 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
16,242 | $10,127,536 | |
| 8 | RARE |
Ultragenyx Pharmaceutical Inc.
|
286,952 | $9,581,327 |
All Filings in INCY
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,311,849 | 56,437 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $256,110 | 2,593 | Shares | Defined | 2026-02-17 | |
| 2025-06-30 | $5,398,150 | 79,268 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $514,675 | 8,500 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $2,312,739 | 33,484 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $2,603,214 | 39,383 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $6,286,294 | 103,700 | Shares | Defined | 2024-11-14 | |
| 2024-03-31 | $4,406,058 | 77,340 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $6,244,338 | 99,448 | Shares | Sole | 2024-10-21 | |
| 2023-09-30 | $345,637 | 5,983 | Shares | Sole | 2024-10-21 | |
| 2023-06-30 | $4,606,997 | 74,008 | Shares | Sole | 2024-10-21 | |
| 2022-12-31 | $643,442 | 8,011 | Shares | Sole | 2023-02-14 | |
| 2022-06-30 | $205,346 | 2,703 | Shares | Sole | 2022-08-09 | |
| 2021-12-31 | $3,603,499 | 49,094 | Shares | Sole | 2022-02-10 | |
| 2020-12-31 | $305,560 | 3,513 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||